Breaking 911: FDA revokes Emergency Use Authorization for Monoclonal Antibody treatment for Covid-19
(media.greatawakening.win)
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (174)
sorted by:
VelocImmune is used in the production of REGEN-COV, not Sotrovimab. VelocImmune is a patented and trademarked Regeneron technology. REGEN-COV comes from mice cells; sotrovimab comes from hamster ovarian cells, apparently.
Sotrovimab leaves the body on average in 50 days. Not sure about REGEN-COV. The modification given to sotrovimab to make it last longer in the human body is of concern.
From what I can gather, people have developed the most issues from the mAbs used for MS and cancers themselves that are given more than once, over a longer period of time. They also are chimera/hybrid antibodies vs. “fully humanized.”
I still have concerns over the mAb treatment, and more research needs to be done. But a lot of that interview—or at least the article about it—seems to be from a doctor repeating big ticket panic items and not reporting on the actual drug facts. Dr. Madej hasn’t seen patients in a couple of years, so I am not sure how trustworthy her cancer diagnoses can be.